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Β Vitamins in Epileptics 
K-Η. Krause*, J.-P. Bonjoura, P. Berlit*, G Kynast*, 
H. Schmidt-Gaykb, L . ArabQ 
a Neurological, bSurgical and c Medical Clinic, University of Heidelberg, F R G ; 
d Department of Vitamin and Nutrition Research, F . Hoffmann-La Roche & Co. A G , 
Basel, Switzerland 
Vitamin B 6 is the only vitamin of the Β group for which a relationship 
to epileptic seizures has been found until now. In newborns, pyridoxine-
dependent seizures are described which can be treated successfully only by 
the intake of pyridoxine and not of the common anticonvulsants. A distur-. 
bance in binding between glutamic acid decarboxylase-apoenzyme and 
pyridoxal phosphate, with the consequence of a reduction of the inhibitory 
neurotransmitter γ-aminobutyric acid, is discussed as the underlying mech­
anism [13]. On the other hand, vitamin B 6 is the only vitamin of the Β 
group which has been found to be reduced by the intake of anticonvulsants 
[3, 5, 11]. In a representative sample of treated epileptics we investigated 
the vitamin status and compared the values with those of a control collec­
tive of the same age group. A total of 620 patients of the Heidelberg outpa­
tient clinic for epileptics, aged 20-40 years, were examined. All patients 
were treated for at least 1 year with anticonvulsants. Over 50% of them 
took more than one type of anticonvulsant drugs. Because of this predom­
inance of combination therapies the total amount and the mean daily dose 
of anticonvulsants administered were calculated for each patient using 
equivalent units, based on the medium therapeutic dose of each anticonvul­
sant.1 The Heidelberg study subjects served as control collective, in which 
1 1 equivalent unit = 50 mg Phenytoin, 30 mg phenobarbital, 125 mg primidone, 
50 mg CHP-phenobarbital, 200 mg carbamazepine, 50 mg mephenytoin, 250 mg ethosux-
imide, 300 mg valproate sodium, 2 mg clonazepam, 300 mg mesuximide, 100 mg sul-
thiam, or 250 mg trimethadione. 
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Tabic I. Means, standard deviations, medians and 5th and 95th percentiles of Β vitamins in epileptics and 
controls (M - males, F = females) 
η Mean ± SD Median 5th—95th percentile 
epileptics controls epileptics controls epileptics controls epileptics controls 
<*ETK 
Μ 
F 
342 
245 
636 
744 
1.11 ±0 .07 
1.12 + 0.08 
1.12 + 0.07 
1.13 + 0.09 
1.09 
1.11 
1.11 
1.12 
1.01-1.24 
1.01-1.28 
1.01- 1.25 
1.02- 1.28 
Ö E G R 
Μ 
F 
350 
249 
640 
749 
1.15±0.15 
1.18±0.17 
1.11 ±0.11 
1.01 ±0 .07 
1.12 
1.15 
1.10 
0.99 
0.98-1.40 
0.97-1.42 
0.96-1.31 
0.92-1.14 
G E G O T 
Μ 
F 
350 
249 
636 
748 
1.82±0.24 
1.81 ± 0 . 2 4 
1.76 + 0.20 
1.81 ±0 .25 
1.81 
1.81 
1.75 
1.80 
1.43-2.21 
1.41-2.21 
1.45-2.10 
1.44-2.25 
PLP. μ^Ι 
Μ 
F 
347 
246 
640 
746 
4 .05±6 .76 
4.52+ 10.35 
5.67 ±6 .06 
3.35 ±2 .96 
3.20 
3.00 
5.00 
2.90 
1.80-6.86 
1.73-6.10 
3.10-9.29 
1.50-6.16 
B i 2 . pmol/l 
Μ 
F 
344 
240 
727 
712 
368.7+ 163.3 
377.6 ±209 .4 
571.7 + 332.4 
400.3 ±263 .8 
350 
350 
490 
353 
150-707.5 
100.5-740 
210-1,180 
179.6-704.4 
Biotin, ng/i 
Μ 
F 
334 
243 
70 
73 
236 .6±84 .72 
223 ±76 .12 
344.5 ± 106.7 
335 .6±74 .56 
225 
213 
327 
335 
107.5-374 
100-336.4 
230-505.6 
207.1-459 
more than 1,500 healthy persons, aged 20-40 years, were examined [1]. In 
this presentation we report our findings regarding the status of vitamins Bi, 
B 2 , B 6 , B i 2 and biotin in epileptics. 
Vitamin B6 
The vitamin B6 status was assessed in two ways: first by using the 
erythrocyte-glutamate oxaloacetate transaminase (EGOT) test, and second 
by assaying the level of pyridoxal-5-phosphate (PLP) in erythrocytes deter­
mined by the rate of decarboxylation of carbonyl-14C-labelled tyrosine [14]. 
The activation coefficient ( X E G O T was clearly higher and, even more pro­
nounced, the PLP levels were lower in epileptic males than in controls 
(table I). Both these findings indicate an inferior vitamin Be status in male 
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35 Ί 
ι-High—ι Moderate t—LowH \/ery low risk 
Fig. 1. Rates of high (α Ε αοτ >2.00) , moderate (<XEGOT = 1.80-2.00), low ( C I E G O T = 
1.60-1.79) and very low ( α Ε ο ο τ < 1 -60) risk of vitamin B 6 deficiency in male epileptics (1) 
and controls (2). 
epileptics compared to controls. In females no difference in the mean α Ε Ο οτ 
values were noted between epileptics and controls (table I). Mean PLP val­
ues for the female epileptics are seemingly higher than in controls (table I), 
but there is a very high standard deviation in female epileptics caused by 
the extremely high PLP levels of about 100 μg/l in 7 females, probably due 
to the oral intake of vitamin B 6 . When these 7 epileptics were not consid­
ered, the mean PLP level was 3.22 μg/l, not different to the females of the 
Heidelberg study. Of more interest than a comparison of means is the com­
parison of a risk of vitamin B 6 deficiency in both collectives. Regarding 
G E G O T , a greater percentage of subjects at a high and moderate risk of vita­
min B 6 deficiency was found in male epileptics than in controls (fig. 1). The 
risk of vitamin B 6 deficiency in male epileptics is much more pronounced 
when the PLP levels are considered (fig. 2). In females, no difference in the 
risk rates was noted for epileptics and controls. About 50% of the women in 
both groups had a high or moderate risk of vitamin B 6 deficiency 
(fig. 3, 4). 
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Fig. 2. Risk rates of deficiency of pyridoxal-5-phosphate (PLP) in erythrocytes (high: 
< 2.0 μg/l, moderate 2.0-3.0, low 3.1-6.0, very low > 6.0 μ^Ι) in male epileptics (1) and 
controls (2). 
Fig. 3. Risk rates ( α Ε Ο ο τ ) of vitamin B 6 deficiency in female epileptics (1) and controls 
(2) (see fig. 1). 
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50 π 
1 2 1 2 1 2 1 2 
f—High—ι Moderate I—Low—ι Very low risk 
• n 
Fig. 4. Risk rates of P L P deficiency in female epileptics (1) and controls (2) (see 
% 2). 
The reduced vitamin B 6 status in many females of the control group 
could be caused by the intake of hormonal contraceptives [7] which were 
taken by over 50% of these women, compared to less than 3% in the female 
epileptics. Therefore, it seems to be possible that in both female collectives 
the high rate of a risk of vitamin B$ deficiency could be due to drug intake. 
I f we assume that the reduced vitamin B 6 status in epileptics is caused by 
the intake of anticonvulsants, then correlations between vitamin levels and 
the anticonvulsants administered are of great interest. The female patients 
with an oral intake of pyridoxine at the time of examination were excluded 
from these calculations. In epileptic males - but not in females - the total 
amount as well as the mean daily dose and the duration of anticonvulsant 
therapy showed a negative correlation with the levels of PLP and unstimu­
lated EGOT (EGOT0), whereas no correlation was found for ( X E G O T (ta­
ble II). We also looked for correlations between the three parameters of the 
vitamin B 6 status and found that PLP correlated better with unstimulated 
EGOT than with the activation coefficient (table III). The question arises 
why PLP levels and EGOT0 values correlated with the anticonvulsant 
parameters and why ( X E G O T did not. A possible explanation would be that -
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Table II. Spearman's rank correlation coefficients for Β vitamins and data of anticonvulsant therapy 
E T K o α Ε τκ CtEGR E G O T 0 CtEGOT P L P Biotin Β,2 
Mean daily dose of anticonvulsants (equivalent units per day) 
Males 
r -0.1368 0.1163 -0.0089 -0.0832 0.0175 -0.1337 -0.1408 0.0197 
Ρ 0.0123 0.0336 0.8702 0.1276 0.7493 0.0145 0.0111 0.7217 
η 334 334 341 337 337 334 325 331 
Females 
r -0.1236 0.1438 0.1762 -0.0079 -0.0591 -0.0167 -0.0753 -0.0728 
Ρ 0.0559 0.0259 0.0057 0.9026 0.3598 0.7968 0.2462 0.2685 
η 240 240 245 242 242 239 239 233 
Total amount of anticonvulsants (equivalent units) 
Males 
r -0.0461 0.0822 -0.0118 -0.0959 0.00453 -0.1784 -0.1377 0.0475 
Ρ 0.4014 0.1340 0.8287 0.0789 0.9339 0.0011 0.0130 0.3888 
η 334 334 341 337 337 334 325 331 
Females 
r -0.0876 0.0349 0.0865 -0.0200 -0.0652 -0.0292 -0.0674 -0.0133 
Ρ 0.1763 0.5906 0.1771 0.7566 0.3124 0.6539 0.2996 0.8405 
η 240 240 245 242 242 239 239 233 
Duration of therapy (years) 
Males 
r 0.0257 -0.0024 -0.0110 -0.1053 0.0082 -0.1929 -0.1139 0.0386 
Ρ 0.6403 0.9655 0.8402 0.0535 0.8807 0.0004 0.0401 0.4843 
η 334 334 341 337 337 334 325 331 
Females 
r -0.0552 -0.0252 0.0278 -0.0235 -0.0571 -0.0278 -0.0286 0.0220 
Ρ 0.3943 0.6980 0.6649 0.7166 0.3769 0.6693 0.6602 0.7388 
η 240 240 245 242 242 239 239 233 
Table III. Correlation coefficients r between (XEGGT, unstimulated E G O T activity ( E G O T 0 ) 
and pyridoxal-5-phosphate (PLP) in the epileptics 
CtEGOT P L P 
P L P -0.5040 
E G O T 0 -0.6419 0.7001 
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as postulated for alcoholics [2] - a long-standing pyridoxine deficiency leads 
to a decrease of apoenzyme levels. In such cases a low ( X E G O T value would be 
found on stimulation with PLP, and these seemingly normal values would 
erroneously indicate an adequate vitamin B 6 status. Assuming that such 
reduced apoenzyme levels occur in our epileptics, the occurrence of seem-
inlgy normal ( X E G O T values would explain why only the PLP concentrations 
and EGOT0 values correlated with drug parameters. We cannot explain 
why in the females, who also show high risk rates, no correlations have been 
found between vitamin B 6 parameters and anticonvulsant therapy. 
Vitamin Bj 
The thiamin status was assessed using the activation coefficient α Ε Τ κ, 
calculated from the coenzyme stimulation of the transketolase activity in 
erythrocytes [14]. α Ετκ values in epileptics of both sexes were similar to 
those in controls (table I). Nevertheless, anticonvulsants seem to have an 
influence on the vitamin Bj status: in male and female epileptics a positive 
correlation between ( X E T K and a negative one between unstimulated ETK 
activity and the mean daily dose of anticonvulsants was found (table II). 
These findings would then indicate that long-term medication with anticon­
vulsants could increase the risk of vitamin Bi deficiency. About 25% of 
both epileptics and controls had a high or moderate risk of thiamin defi­
ciency (fig. 5, 6). 
Vitamin B2 
When examining the vitamin B2 status using the erythrocyte gluta­
thione reductase activation test [14], unexpected results were obtained: in 
male epileptics a slight, in female epileptics a distinct deterioration of the 
riboflavin status was found, compared with controls (table I). This is con­
firmed when risk groups are considered (fig. 7, 8): about 40% of the female 
epileptics showed a high or moderate risk of vitamin B 2 deficiency, whereas 
practically none of the females of the control group did. Epileptic males 
showed no correlation between the activation coefficient C X E G R and anticon­
vulsants, but in females a positive correlation between the daily dose of 
anticonvulsants and G I E G R was found (table II). 
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50-. 
ι—High—I Moderate I— Low—ι Very low risk 
Fig. 5. Rates of high ( a E T K > 1.25), moderate ( α Ε Τ κ = 1.16-1.25), low ( α Ε Τ κ = 1.08-
1.15) and very low (α Ε τκ < 108) risk of thiamine deficiency in male epileptics (1) and 
controls (2). 
50 π 
I—High—I Moderate ·—LowH Very low risk 
Fig. 6. Risk rates of thiamin deficiency in female epileptics (1) and controls (2) (see 
fig. 5). 
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6 0 -
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lU 
1 2 
Very low risk 
Fig. 7. Rates of high ( a E G R > 1-28), moderate (a EGR = 1.20-1.28), low ( a E G R = 1.03-
1.19) and very low (a EGR < 1-03) risk of riboflavin deficiency in male epileptics (1) and 
controls (2). 
70 
60 Η 
50 
40 -\ 
30 
20 
c 10 
Qj 
u 
£ ο I L L 
1 2 1 2 I-High Η Moderate l~Low- Very low risk 
Fig. 8. Risk rates of riboflavin deficiency in female epileptics (1) and controls (2) (see 
fig. 7). 
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Vitamin B}2 
No difference in the mean vitamin B[2 levels, which were determined 
in serum by a radioimmunoassay, were noted between female and male 
epileptics, whereas in the Heidelberg study distinctly lower mean vitamin 
Β12 concentrations were found in females than in males (table I). When 
comparing the two collectives, no difference in mean vitamin Β12 levels was 
detected in females, but the male epileptics had much lower levels than the 
controls. This tendency is confirmed in the risk rates: 15% of the male and 
1% of the female epileptics had a high or moderate risk of vitamin B12 
deficiency compared with 6 and 12%, respectively, in the controls (fig. 9, 
10). The relatively frequent occurrence of deficient levels in the female 
controls could be due to the intake of oral contraceptives for which a neg­
ative correlation with vitamin B j 2 levels had been detected in the Heidel­
berg study [1]. The reason for the low levels in our epileptics is not clear, 
because no correlations with anticonvulsant intake were found either in 
males or in females. In 1966, Reynolds et al. [12] reported a small reduction 
of Β12 levels in epileptics; other studies, which were done after the descrip­
tion of megaloblastic anemias as side effect of anticonvulsant therapy, 
failed to show an influence of anticonvulsants on the vitamin B i 2 status 
[4, 8]. 
Biotin 
The last vitamin discussed here, possibly with the most striking results, 
is biotin. This vitamin has not been investigated in the Heidelberg study; 
therefore, a collective of blood donors served as controls. Their plasma was 
analyzed in the same laboratory using the same method, namely a micro­
biological assay with Lactobacillus plantarum as test organism [6]. The 
plasma biotin levels were clearly reduced in epileptics, both in males and in 
females (table I), and very high rates for a high and moderate risk of biotin 
deficiency were found in our epileptics (fig. 11, 12). In male epileptics there 
was a negative correlation with anticonvulsant medication (table I I , 
fig. 13). 
As our further investigations have shown, this reduced biotin status has 
biochemical consequences: in epileptics with low biotin levels abnormal 
organic acids (such as methylcrotonylglycine, methyl citric acid or propio-
nylglycine) are excreted in the urine [10]. Interesting hypotheses concerning 
the possible mode of action of anticonvulsants can be postulated from these 
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80 η 
7 0 -
6 0 -
5 0 -
I—High—ι Moderate I-Low—I Very low risk 
Fig. 9. Rates of high ( < 150μηιο1/1), moderate (150-220), low (221-350) and very 
low ( > 350 μΐΏοΙ/l) risk of vitamin B t ? deficiency in male epileptics (1) and controls (2). 
50 η 
Η High—I Moderate I—Low Η Very low risk 
Fig. 10. Risk rates of vitamin B | 2 deficiency in female epileptics (1) and controls (2) 
(see fig. 9). 
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Fig. 11. Rates of high ( < 250 ng/1), moderate (250-300) and low ( > 300 ng/1) risk of 
biotin deficiency in male epileptics ( I ) and controls (2). 
Fig. 12. Risk rates of biotin deficiency in female epileptics (1) and controls (2) (see 
fig. 11). 
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F/g. / J . Correlation between daily intake of anticonvulsants and biotin in male epi­
leptics. 
findings [9]: the biotin-dependent carboxylases are involved in biochemical 
reactions which influence inhibitory and excitatory neurotransmitters. Fur­
thermore, the carboxylases are important in the metabolism of carbon diox­
ide, which directly influences the seizure threshold. Further investigations 
are planned to determine the effect of the biotin status on the clinical 
expression of epilepsy. 
Conclusion 
All in all, we found a poorer status of the vitamins B 2 , B 6 , B ! 2 and 
biotin in long-term treated epileptics compared with a control collective 
from the same area. These changes cannot be explained by alimentary fac­
tors alone, as the epileptics investigated were selected from an outpatient 
clinic and generally lead a normal life. The direct influence of antiepileptic 
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medication on the status seen for vitamins B h B 2 , B 6 and biotin is a factor 
to be considered. Further investigations elucidating the mechanism of this 
influence of anticonvulsants on the vitamin Β status are therefore of high 
interest. At this time we cannot definitely say whether a substitution with Β 
vitamins should be recommended in long-term treated epileptics. 
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